The potential of lumbrokinase and serratiopeptidase for the degradation of Aß 1-42 peptide - an <i>in vitro</i> and <i>in silico</i> approach.

Metkar, Sanjay Kisan; Girigoswami, Agnishwar; Bondage, Devanand D; Shinde, Umakant G; Girigoswami, Koyeli

The potential of lumbrokinase and serratiopeptidase for the degradation of Aß 1-42 peptide - an in vitro and in silico approach.

Metkar, Sanjay Kisan; Girigoswami, Agnishwar; Bondage, Devanand D; Shinde, Umakant G; Girigoswami, Koyeli.

Afiliación

Metkar SK; Medical Bionanotechnology, Faculty of Allied Health Sciences, Chettinad Hospital and Research Institute (CHRI), Chettinad Academy of Research and Education (CARE), Chettinad Health City, Chennai, India.
Girigoswami A; Medical Bionanotechnology, Faculty of Allied Health Sciences, Chettinad Hospital and Research Institute (CHRI), Chettinad Academy of Research and Education (CARE), Chettinad Health City, Chennai, India.
Bondage DD; Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA.
Shinde UG; Centre for Advanced Life Sciences (CFALS), Deogiri College, Aurangabad, Maharashtra, India.
Girigoswami K; Medical Bionanotechnology, Faculty of Allied Health Sciences, Chettinad Hospital and Research Institute (CHRI), Chettinad Academy of Research and Education (CARE), Chettinad Health City, Chennai, India.

Int J Neurosci ; : 1-12, 2022 Jun 27.

Article en En | MEDLINE | ID: mdl-35694981

Palabras clave

Alzheimer's disease; Lumbrokinase; amyloid degradation; amyloidosis; fatal neurodegenerative disorders; serratiopeptidase

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Int J Neurosci Año: 2022 Tipo del documento: Article País de afiliación: India Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google